Search results
Results From The WOW.Com Content Network
June 28, 2024 at 10:52 PM. By Brendan Pierson. (Reuters) - A federal judge on Friday rejected a bid by a group of cancer victims to block Johnson & Johnson from pursuing a proposed bankruptcy ...
Title 11 of the United States Code. Harrington v. Purdue Pharma L.P., 603 U.S. ___ (2024), is a United States Supreme Court case regarding Chapter 11 of the Bankruptcy Code. [ 1] This case is about the settlement by Purdue Pharmaceutical for opioid victims who overdosed with the OxyContin drug produced by their company.
Insys Therapeutics. Founded in 1990, Insys Therapeutics was an American specialty pharmaceutical company based in Chandler, Arizona. [ 1] Its main product was Subsys, a sublingual liquid form of the drug fentanyl. Fentanyl is an extremely fast-acting and powerful opioid used to relieve peaks of pain in cancer patients. [ 2][ 3]
Richard Stephen Sackler (born March 10, 1945) [ 1] is an American businessman and physician who was the chairman and president of Purdue Pharma, a former company best known as the developer of OxyContin, whose initiation of the opioid epidemic in the United States became the subject of many lawsuits and fines, filing for bankruptcy in 2019. [ 2 ...
July 30, 2024 at 5:04 PM. By Daniel Wiessner. (Reuters) -Wells Fargo & Co was accused in a lawsuit filed on Tuesday of mismanaging its employee health insurance plan and forcing tens of thousands ...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 26) AstraZeneca plc (NYSE: AZN )(announced ...
1. 2015. Pfizer. Allergan, plc. 160. 206. In November 2015 Pfizer announced it would acquire Allergan, plc for $160 billion ($206 billion, adjusted for inflation). However, this deal was cancelled in April 2016 due to new US tax inversion rules. [ 12][ 13] Had this transaction been completed, this would have been the largest within this industry.
Cano Health has emerged from bankruptcy with more than $200 million in new funding from existing investors. And instead of paying all the money it owed to creditors, the company said it struck a ...